Roche signs $1B deal with Dualitas to pair up on big bispecific screening drive

Posted inBiotechnology

Roche is paying Dualitas Therapeutics $36.5 million upfront to screen over 300,000 novel bispecific combinations in search of new treatments for immunology and inflammation diseases.